Top Abstract Purchase Related
Home
>
Node
>
Subnode

Expression of MAGE A 1-6 mRNA in sputa of head and neck cancer patients--a preliminary report

Lee, K.Dae.; Lee, H.Ho.; Joo, H.Bum.; Lee, H.Shin.; Yu, T.Hyun.; Chang, H.Kyung.; Jeon, C.Ho.; Park, J.Wook.

Anticancer research 26(2B): 1513-1518

2006

ISSN/ISBN: 0250-7005
PMID: 16619566
Document Number: 604309
The applicability of the melanoma antigen gene (MAGE) to the molecular diagnosis of cancer, by detecting MAGE mRNA in the sputa of head and neck cancer patients, was investigated. Nested reverse transcription-polymerase chain reaction (RT-PCR) with the MAGE common primers designed to detect MAGE A1-6 genes was conducted with sputa of 17 head and neck squamous cell carcinoma patients. Of the 17 sputa specimens from patients with squamous cell carcinoma, MAGE mRNA was detected in 13 cases, while the detection rate was 2 out of 40 in the normal control group, showing significant correlation (p<0.05) between head and neck squamous cell carcinoma and MAGE mRNA expression in sputa. MAGE may be a useful tumor marker of head and neck cancer.

Document emailed within 1 workday
Secure & encrypted payments

Krawczyk, A.; Płochowski, J.; Dragan, S.; Orzechowski, W.; Kulej, Mław.; Koprowski, P. 2008: Elliptical head hemiarthroplasty in the treatment of femoral neck and head fractures--preliminary report Ortopedia, Traumatologia, Rehabilitacja 10(4): 331-337
Andratschke, M.; Pauli, C.; Stein, M.; Chaubal, S.; Wollenberg, B. 2003: MHC-class i antigen expression on micrometastases in bone marrow of patients with head and neck squamous cell cancer Anticancer Research 23(2b): 1467-1471
Muramatsu, H.; Akimoto, T.; Maebayashi, K.; Kita, M.; Mitsuhashi, N. 2008: Prognostic significance of dysadherin and E-cadherin expression in patients with head and neck cancer treated by radiation therapy Anticancer Research 28(6b): 3859-3864
Saito, H.; Ono, I.; Ebihara, S.; Yoshizumi, T.; Ikeda, S.; Ono, R. 1985: Cases of head and neck carcinoma detected by sputum cytology--lung cancer screening and head and neck cancer Gan no Rinsho. Japan Journal of Cancer Clinics 31(13): 1665-1668
Peng, J.; Cai, S.; Leng, X.; Mu, D.; Lu, J.; Chen, H.; Rui, J. 2002: MRNA of MAGE genes as specific markers in detection of tumor cells in the peripheral blood of patients with hepatocellular carcinoma Zhonghua Yu Fang Yi Xue Za Zhi 36(7): 487-490
Kapranos, N.; Stathopoulos, G.P.; Manolopoulos, L.; Kokka, E.; Papadimitriou, C.; Bibas, A.; Yiotakis, J.; Adamopoulos, G. 2001: P53, p21 and p27 protein expression in head and neck cancer and their prognostic value Anticancer Research 21(1b): 521-528
Charuruks, N.; Shin, D.M.; Voravud, N.; Ro, J.Y.; Hong, W.K.; Hittelman, W.N. 1999: P53 expression and polysomies of chromosome 9, 17 in head and neck cancer prognosis Journal of the Medical Association of Thailand 82(5): 466-476
Witt, R.; Schneider, C.; Raben, A.; Arm, R.; Kendall, J.; Symes, K.; Waddington, C.; Dolinger, E.; Casper, J.; Harrington, M. 2003: Head and neck cancer care in Delaware: the advent of the Helen F. Graham Head and Neck Multi-Disciplinary Center Delaware Medical Journal 75(12): 455-459
Tu, G.-y.; Xu, Z.-g.; Liu, S.-y. 2009: From head and neck surgery to head and neck oncology: the disciplinary guarantee for comprehensive cancer therapy Zhonghua Zhong Liu Za Zhi 31(11): 877-879
Ozawa, H.; Matsunaga, T.; Kamiya, K.; Tokumaru, Y.; Fujii, M.; Tomita, T.; Ogawa, K. 2007: Decreased expression of connexin-30 and aberrant expression of connexin-26 in human head and neck cancer Anticancer Research 27(4b): 2189-2195
Bolla, M.; Vrousos, C.; Roux, O.; Agnius-Delord, C.; Junien-Lavillauroy, C.; Lachet, B. 1980: Carcinoembryonic antigen in cancers of the head and neck. Preliminary results in 72 patients Journal Francais d'Oto-Rhino-Laryngologie; Audiophonologie Chirurgie Maxillo-Faciale 29(5): 309-314
Frata, P.; Ponticelli, P.; Cosentino, D.; Buffoli, A.; Di Pilla, A.; Morrica, B.; Palazzi, M. 2008: Radiotherapy resources for the care of head and neck patients in Italy. A survey by the head and neck group of the Italian Association for Radiation Oncology (AIRO) Tumori 94(1): 59-64
Laohawiriyakamol, S.; Sunpaweravong, S.; Leelamanit, V.; Pruegsanusak, K.; Sinkijcharoenchai, W. 2014: Evaluating synchronous esophageal cancer in head and neck cancer patients using Lugol dye chromoendoscopy Journal of the Medical Association of Thailand 97(11): 1164-1170
Strohm, M. 1978: Report of the "Head and Neck Cancer Conference" UICC, 16./17. September 1977, Essen. Hno 26(6): 185-190
Lertbutsayanukul, C.; Khorprasert, C.; Shotelersuk, K.; Jumpangern, C.; Sanghangthum, T.; Oonsiri, S.; Ayuthaya, I.Israngkul.Na.; Suriyapee, S.; Wadwongtham, W.; Supanakorn, S.; Kerekanjanarong, V.; Rojpornpradit, P. 2006: Intensity-modulated radiation therapy in head-and-neck cancer, first report in Thailand Journal of the Medical Association of Thailand 89(12): 2068-2076
Corvò, R.; Foppiano, F.; Bacigalupo, A.; Berretta, L.; Benasso, M.; Vitale, V. 2004: Contralateral parotid-sparing radiotherapy in patients with unilateral squamous cell carcinoma of the head and neck: technical methodology and preliminary results Tumori 90(1): 66-72
Steffee, W.P.; Krey, S.H. 1980: Enteral hyperalimentation for patients with head and neck cancer Otolaryngologic Clinics of North America 13(3): 437-448
Miyazato, H.; Tamai, O.; Tomita, S.; Shiraishi, M.; Kusano, T.; Muto, Y.; Koja, S. 1997: Esophageal cancer in patients with head and neck cancers International Surgery 82(3): 319-321
Mimatsu, K.; Irifune, B. 1972: Feeding of patients following surgery for cancer of the head and neck Nursing Technique 18(8): 63-71
Pratt, L.L. 1977: Workup and staging of patients with head and neck cancer Seminars in Oncology 4(4): 357-363